[1]蔺楠,张丽,童冠圣,等.18F-FDG注射残留放射性活度影响因素的分析[J].国际放射医学核医学杂志,2018,(6):491-494.[doi:10.3760/cma.j.issn.1673-4114.2018.06.003]
 Lin Nan,Zhang Li,Tong Guansheng,et al.Analysis of factors affecting the residual radioactive activity of injection of 18F-FDG[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(6):491-494.[doi:10.3760/cma.j.issn.1673-4114.2018.06.003]
点击复制

18F-FDG注射残留放射性活度影响因素的分析(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
期数:
2018年第6期
页码:
491-494
栏目:
临床研究
出版日期:
2018-12-31

文章信息/Info

Title:
Analysis of factors affecting the residual radioactive activity of injection of 18F-FDG
作者:
蔺楠 张丽 童冠圣 蔡炯
1. 100038, 首都医科大学附属北京世纪坛医院核医学科;
2. 100730, 中国医学科学院北京协和医院核医学科
Author(s):
Lin Nan Zhang Li Tong Guansheng Cai Jiong
1. Department of Nuclear Medicine, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China;
2. Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing 100730, China
关键词:
氟脱氧葡萄糖F18放射性活度药物残留
Keywords:
Fluorodeoxyglucose F18RadioactivityDrug residues
DOI:
10.3760/cma.j.issn.1673-4114.2018.06.003
摘要:
目的 分析18F-FDG药物注射过程中影响其注射后残留放射性活度的因素,以指导临床放射性药物的分装。方法 收集2017年10月至12月在首都医科大学附属北京世纪坛医院核医学科行PET/CT检查的患者100例,按其注射药物的体积和放射性活度分组,用放射性活度计记录注射后注射器针筒、注射器针头、三通及头皮针残留的放射性活度以及空气中的放射性本底,并对总残留放射性活度和注射药物的放射性浓度进行曲线拟合。采用SPSS 17.0统计学软件进行正态分布检验及Spearman相关性分析。结果 注射后注射器针筒、注射器针头、三通及头皮静脉针残留的放射性活度的中位数(四分位距)分别为1.59(0.93)、3.35(3.43)、1.70(0.92)MBq,总残留放射性活度为7.09(4.31)MBq;总残留放射性活度与18F-FDG注射药物的放射性浓度呈正相关(r=0.594,P<0.01),对其进行曲线拟合,放射性浓度<600 MBq/mL为宜。结论18F-FDG浓度进行稀释,降低其放射性浓度能减少总残留放射性活度,精确注射药物活度,同时能够降低对工作人员的受照剂量。
Abstract:
Objective The factors influencing residual radioactivity in 18F-FDG injection were analyzed to guide the packing of radiopharmaceuticals. Methods A total of 100 patients subjected to 18F-FDG PET/CT in Beijing Shijitan Hospital from October 2017 to December 2017 were analyzed. Patients were divided into different groups based on the volume and radioactivity of the radiopharmaceuticals they received. The residual radioactivity of the syringe tube, syringe needle, three-way valve, scalp needle, and background was then measured separately using a radioactivity meter. The curve of the total residual radioactivity as a function of 18F-FDG concentration was then fitted. SPSS 17.0 statistical software was used to test the normality of the data distribution, and results were analyzed by Spearman correlation. Results The residual radioactivity values of the syringe needle tube, syringe needle, three-way valve, and scalp intravenous needle were 1.59(0.93), 3.35(3.43), and 1.70(0.92) MBq, respectively. The total residual radioactivity was 7.09(4.31 MBq) and significantly related to the concentration of 18F-FDG applied(r=0.594, P<0.01). According to the fitting curve obtained, the appropriate radioactivity concentration of 18F-FDG is less than 600 MBq/mL. Conclusions In clinical work, appropriate dilution of the 18F-FDG injection volume and decreasing the radioactivity of pharmaceuticals can effectively reduce the total residual radioactivity of the procedure. Medical institutions should measure the appropriate dilution concentration of radioactive drugs according to the specifications of the syringes to increase the precision of injection and reduce the irradiation dose of the staff.

参考文献/References:

[1] Adams MC, Turkington TG, Wilson JM, et al. A systematic review of the factors affecting accuracy of SUV measurements[J]. AJR Am J Roentgenol, 2010, 195(2):310-320. DOI:10.2214/AJR.10.4923.
[2] 郑均正. 电离辐射医学应用的防护与安全[M]. 北京:原子能出版社, 2009:284-285. Zheng JZ. Protection and safety of medical applications of ionizing radiation[M]. Beijing:Atomic Energy Press, 2009:284-285.
[3] 曹晓征. 正电子发射断层显像检查中显像剂的注射方法比较[J]. 中国实用医药, 2013, 8(10):110-111. DOI:10.3969/j.issn.1673-7555.2013.10.078. Cao XZ. Comparison of injection methods of imaging agents in positron emission tomography[J]. China Prac Med, 2013, 8(10):110-111. DOI:10.3969/j.issn.1673-7555.2013.10.078.
[4] 李洁明, 刘晓华, 饶国辉, 等. 不同容积注射器放射性残留量对患者核医学检查效果的影响及护理[J]. 现代临床护理, 2008, 7(10):16-17, 37. DOI:10.3969/j.issn.1671-8283.2008.10.006. Li JM, Liu XH, Rao GH, et al. Effect of Radioactive Residues of Different Volume Syringes on Patients’ Nuclear Medical Examination and Nursing Care[J]. Mod Clin Nurs, 2008, 7(10):16-17, 37. DOI:10.3969/j.issn.1671-8283.2008.10.006.
[5] 刘慧萍, 武惠萍, 郭会萍. 一次性小剂量注射器无效腔容量的探讨[J]. 全科护理, 2006, 4(15):28-29. DOI:10.3969/j.is]sn.1674-4748.2006.15.017. Liu HP, Wu HP, Guo HP. Invalid cavity capacity of disposable small dose syringe[J]. Fam Nurs, 2006, 4(15):28-29. DOI:10.3969/j.issn.1674-4748.2006.15.017.
[6] 谢欢, 林惠明, 陈英. 从注射剂装量检测探讨注射器死腔残留量[J]. 护理学杂志, 2017, 32(19):69-70. DOI:10.3870/j.issn.1001-4152. 2017.19.069. Xie H, Lin HM, Chen Y. Dead space volume of syringe:a perspective from medical agent injection volume[J]. J Nurs Sci, 2017, 32(19):69-70. DOI:10.3870/j.issn.1001-4152.2017.19.069.
[7] 张巍, 李士雪, 李连波, 等. 医院PET-CT中心18F正电子放射性药物生产及使用中工作人员的辐射剂量监测[J]. 山东大学学报(医学版), 2012, 50(12):126-129. DOI:10.6040/j.issn.1671-7554. 2012.12.026. Zhang W, Li SX, Li LB, et al. Measurement and evaluation of personal radiation dose in cyclotron center and PET-CT department[J]. J Shandong Univ Health Sci, 2012, 50(12):126-129. DOI:10.6040/j.issn.1671-7554.2012.12.026.
[8] 彭立华, 张锦艳. 核医学医务人员的职业风险分析与放射防护措施[J]. 中国伤残医学, 2013, 21(6):384. DOI:10.3969/j.issn.1673-6567.2013.06.339. Peng LH, Zhang JY. Occupational Risk Analysis and Radiation Protection Measures of Medical Staff in Nuclear Medicine[J]. Chinese Journal Trauma Disability Medicine, 2013, 21(6):384. DOI:10.3969/j.issn.1673-6567.2013.06.339.

相似文献/References:

[1]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
 Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[2]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
 You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[3]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
 Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[4]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
 Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[5]许靖,李肖红,秦永德,等.帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究[J].国际放射医学核医学杂志,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
 Xu Jing,Li Xiaohong,Qin Yongde,et al.Clinical study of brain glucose metabolism and brain dopamine transporter PET imaging in patients with Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
[6]曹登敏,林美福,陈文新,等.继发性骨淋巴瘤的18F-FDG PET/CT影像学表现[J].国际放射医学核医学杂志,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
 Cao Dengmin,Lin Meifu,Chen Wenxin,et al.Analysis on 18F-FDG PET/CT imaging characteristics in secondary bone lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
[7]李生栩,唐明灯,林端瑜,等.18F-FDG PET/CT在胸段食管鳞癌淋巴结转移中的诊断价值[J].国际放射医学核医学杂志,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
 Li Shengxu,Tang Mingdeng,Lin Duanyu,et al.Value of 18F-FDG PET/CT in detecting metastatic lymph nodes of thoracic esophageal squamous cell carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
[8]张莹莹,王振光,武凤玉,等.特发性肺间质纤维化HRCT病变区与非病变区18F-FDG PET/CT表现分析[J].国际放射医学核医学杂志,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
 Zhang Yingying,Wang Zhenguang,Wu Fengyu,et al.18F-FDG PET/CT imaging analysis of regions with abnormal and normal pulmonary parenchyma on high resolution CT in idiopathic pulmonary fibrosis patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
[9]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
 Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[10]郝新忠,武志芳,武萍,等.SAPHO综合征18F-FDG PET/CT显像和临床分析[J].国际放射医学核医学杂志,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
 Hao Xinzhong,Wu Zhifang,Wu Ping,et al.18F-FDG PET/CT imaging and clinical features of SAPHO syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]

备注/Memo

备注/Memo:
收稿日期:2018-04-03。
通讯作者:蔡炯,Email:huohuofan1104@126.com
更新日期/Last Update: 2018-12-31